Market Tracker

12/08 11:02am ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.18
Delayed Data
As of 10:34am ET
 +0.0325 / +1.03%
Today’s Change
1.62
Today|||52-Week Range
5.79
-2.97%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.15
Today’s open3.20
Day’s range3.17 - 3.20
Volume20,046
Average volume (3 months)1,065,201
Market cap$150.8M
Dividend yield--
Data as of 10:34am ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc-0.01-0.71%
CTICCTi Biopharma Corp+0.01+2.17%
RDHLRedhill Biopharma Lt...+0.08+0.71%
ZYNEZynerba Pharmaceutic...+0.14+0.96%
Data as of 10:47am ET, 12/08/2016

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts